Cardiac risk information

Practice Point

Cardiac risk information

Inform patients and their GPs of potential cardiac risks associated with treatment, the importance of ongoing monitoring and management of cardiac health and cardiovascular risk factors based on their baseline and future risk of cardiac dysfunction, and, encourage a heart-healthy lifestyle.

How this guidance was developed

This practice point is informed by several source recommendations which recommend a comprehensive assessment of cardiovascular health and cardiovascular risk factors before and after cancer treatment (ASCO 2017). The importance of communicating this information to patients and their primary care providers (GPs) was considered an important aspect of care that is not included in existing guidelines.

It is acknowledged that traditional cardiac risk factors, as well as therapy-related risk factors, may be predictive of cancer therapy-related cardiac dysfunction (as per the Position Statement and new risk assessment tools from the cardio-oncology study group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society 2020)

Cardiac risk information

Practice Point

Inform patients and their GPs of potential cardiac risks associated with treatment, the importance of ongoing monitoring and management of cardiac health and cardiovascular risk factors based on their baseline and future risk of cardiac dysfunction, and, encourage a heart-healthy lifestyle.

Principles in action
Image
Multidisciplinary care
Image
Supportive care
Image
Care coordination
Image
Communication

This practice point is informed by several source recommendations which recommend a comprehensive assessment of cardiovascular health and cardiovascular risk factors before and after cancer treatment (ASCO 2017). The importance of communicating this information to patients and their primary care providers (GPs) was considered an important aspect of care that is not included in existing guidelines.

It is acknowledged that traditional cardiac risk factors, as well as therapy-related risk factors, may be predictive of cancer therapy-related cardiac dysfunction (as per the Position Statement and new risk assessment tools from the cardio-oncology study group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society 2020)